We previously showed that four of these MS risk genes (MALT1, RCOR1, AFF1 and CD200R1) were expressed in an MS risk SNP genotype-dependent manner and were more associated with the LCL context than that of other immune cells [14]. This evidence concerns the gene CD200R1 and myeloid sarcoma.